T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease
Authors:
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 27 (8) , 1126-1136
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Consensus statement on the pathology of IgG4-related diseaseLaboratory Investigation, 2012
- Cytokinergic IgE Action in Mast Cell ActivationFrontiers in Immunology, 2012
- Mast Cell: An Emerging Partner in Immune InteractionFrontiers in Immunology, 2012
- Rituximab for the Treatment of IgG4-Related DiseaseMedicine, 2012
- A novel clinical entity, IgG4-related disease (IgG4RD): general concept and detailsModern Rheumatology, 2011
- Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseasesImmunological Reviews, 2011
- Transforming growth factor beta 1 plays an important role in inducing CD4+CD25+forhead box P3+ regulatory T cells by mast cellsClinical and Experimental Immunology, 2010
- IgG4‐related disease: Historical overview and pathology of hematological disordersPathology International, 2010
- Endosomal trafficking of the ligated FcɛRI receptorMolecular Immunology, 2009
- Polyclonal IgE Induces Mast Cell Survival and Cytokine ProductionAllergology International, 2009